Skip to content

XenoSure® Biologic Patch

by LeMaitre Vascular, Inc. United States EUDAMED

Ref 2BV9

EMDN P07020101

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-00840663106134 Basic UDI-DIDate16 Apr 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 23 Oct 2026

Device Name
Xenosure Biologic Patch
Model / Reference
2BV9
Primary DI / UDI-DI
00840663106134
Basic UDI-DI
B-00840663106134
EMDN Code
P07020101 Pericardium vascular patches
Device Class
Class III
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
US-MF-000016778
Authorised representative
LeMaitre Vascular GmbH DE-AR-000013539

From the manufacturer

Manufacturer's product page: XenoSure® Biologic Patch

Other devices from LeMaitre Vascular, Inc.

See all devices from LeMaitre Vascular, Inc. →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
  • Animal Tissues
Other properties (8)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 23e8409d-5574-4512-945d-d69c546507e0 61 fields · synced 23 Oct 2026